BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)
$9.11 0.19 (2.13%)
Analysed BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) News Sources
BioCryst (BCRX) Q1 2026 Earnings Transcript
06-05-2026
fool.com
A Look At BioCryst Pharmaceuticals (BCRX) Valuation After Q1 Results And Navenibart Licensing Deal
12-05-2026
yahoo.com
BioCryst (BCRX) Is Down 6.7% After Q1 Loss And Navenibart Deal News Has The Bull Case Changed?
12-05-2026
yahoo.com
BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026
13-05-2026
yahoo.com
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
27-05-2026
yahoo.com
BioCryst Pharmaceuticals Backs ORLADEYO Outlook as Navenibart Trial Advances
06-06-2026
marketbeat.com
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09-06-2026
yahoo.com
WCG Appoints Anthony Doyle as Chief Financial Officer to Support Continued Growth and Operational Scale
11-06-2026
yahoo.com
Is BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy Now?
11-06-2026
yahoo.com
BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of HAE Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
12-06-2026
yahoo.com
What is the current price of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The current price of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is $9.11.
BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) since the previous trading day is $0.19.
BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) since the previous trading day is 2.13%.
What is the most recent average sentiment score for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The most recent average sentiment score for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The most recent sentiment for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is .
SEC-8K** Filing Available For BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.